WHO Requests 20 Million to Prevent Re Emergence of Ebola

There are no new cases of Ebola reported in the Democratic Republic of Congo since 17 February 2020. The World Health Organization requests $20 million to maintain surveillance and response operations until the end of the outbreak declaration. The WHO has not received new funding for the Ebola response since December 2019. 



‘Against all odds’: The inside story of how scientists across three continents produced an Ebola vaccine

For years, researchers who studied Ebola had tried to develop vaccines and drugs to combat the virus. And for years, they had seen promising work stimied by no potential for drug makers to recoup development costs; and the sporardic nature of Ebola outbreaks provided little opportunity to subject experimental vaccines to rigorous tests.

Risk assessment of Ebola virus disease spreading in Uganda using a two-layer temporal network

Researchers presented a novel method for risk assessment based on a two-layer temporal network. The method has the ability to assess the risk of Ebola virus disease spreading. Simulation results from the two-layer temporal network confirmed that reduced physical contact with people while travelling along with other preventive measures decreases the risk of Ebola spreading.

FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens

The US Food and Drug Administration (FDA) has allowed marketing of a rapid diagnostic test (RDT) to detect Ebola virus antigens (proteins) in human blood from certain living individuals and samples from certain recently deceased individuals suspected to have died from Ebola. This is the first rapid diagnostic test the FDA has allowed to be marketed in the US for the Ebola Virus Disease (EVD).